Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions

References

• Temian DC, Pop LA, Irimie AI, Berindan-Neagoe I. The epigenetics of triple-negative and basal-like breast cancer: current knowledge. J Breast Cancer. 2018;21(3):233–243. doi:10.4048/jbc.2018.21.e4130275851
   PubMed Web of Science ®Google Scholar
• Braicu C, Chiorean R, Irimie A, et al. Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy. Expert Rev Mol Med. 2016;18:e18. doi:10.1017/erm.2016.1727817751
   PubMed Web of Science ®Google Scholar
• WHO. Breast cancer: prevention and control; 2020 Available from: https://www.who.int/cancer/detection/breastcancer/en/. Accessed 108, 2020.
   Google Scholar
• Bandyopadhyay S, Bluth MH, Ali-Fehmi R. Breast carcinoma: updates in molecular profiling 2018. Clin Lab Med. 2018;38(2):401–420. doi:10.1016/j.cll.2018.02.00629776638
   PubMed Web of Science ®Google Scholar
• Hurvitz S, Mead M. Triple-negative breast cancer: advancements in characterization and treatment approach. Curr Opin Obstet Gynecol. 2016;28(1):59–69. doi:10.1097/GCO.000000000000023926694831
   PubMed Web of Science ®Google Scholar
• Lovitt CJ, Shelper TB, Avery VM. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer. 2018;18(1):41. doi:10.1186/s12885-017-3953-629304770
   PubMedGoogle Scholar
• AbuHammad S, Zihlif M. Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics. 2013;101(4):213–220. doi:10.1016/j.ygeno.2012.11.00923201559
   PubMed Web of Science ®Google Scholar
• Kobayashi T. Cancer hyperthermia using magnetic nanoparticles. Biotechnol J. 2011;6(11):1342–1347. doi:10.1002/biot.20110004522069094
   PubMed Web of Science ®Google Scholar
• Kossatz S, Grandke J, Couleaud P, et al. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res. 2015;17:66. doi:10.1186/s13058-015-0576-125968050
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18):3995–4021. doi:10.1016/j.biomaterials.2004.10.01215626447
   PubMed Web of Science ®Google Scholar
• Nguyen VTA, De Pauw-gillet M-C, Gauthier M, Sandre O. Magnetic polyion complex micelles for cell toxicity induced by radiofrequency magnetic field hyperthermia. Nanomater (Basel, Switzerland). 2018;8(12). doi:10.3390/nano8121014
   Google Scholar
• Kulshrestha P, Gogoi M, Bahadur D, Banerjee R. In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia. Colloids Surf B Biointerfaces. 2012;96:1–7. doi:10.1016/j.colsurfb.2012.02.02922521681
   PubMed Web of Science ®Google Scholar
• Deatsch A, Evans B. Heating efficiency in magnetic nanoparticle hyperthermia. J Magn Magn Mater. 2014;354:163–172. doi:10.1016/j.jmmm.2013.11.006
   Web of Science ®Google Scholar
• Tombacz E, Turcu R, Socoliuc V, Vekas L. Magnetic iron oxide nanoparticles: recent trends in design and synthesis of magnetoresponsive nanosystems. Biochem Biophys Res Commun. 2015;468(3):442–453. doi:10.1016/j.bbrc.2015.08.03026275707
   PubMed Web of Science ®Google Scholar
• Nguyen D, Kim K. Controlled synthesis of monodisperse magnetite nanoparticles for hyperthermia-based treatments. Powder Technol. 2016;301:1112–1118. doi:10.1016/j.powtec.2016.07.052
   Web of Science ®Google Scholar
• Bakhtiary Z, Saei AA, Hajipour MJ, Raoufi M, Vermesh O, Mahmoudi M. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: possibilities and challenges. Nanomedicine. 2016;12(2):287–307. doi:10.1016/j.nano.2015.10.01926707817
   PubMed Web of Science ®Google Scholar
• Fortes Brollo ME, Dominguez-Bajo A, Tabero A, et al. Combined magnetoliposome formation and drug loading in one step for efficient alternating current-magnetic field remote-controlled drug release. ACS Appl Mater Interfaces. 2020;12(4):4295–4307. doi:10.1021/acsami.9b2060331904927
   PubMed Web of Science ®Google Scholar
• Linh PH, Phuc NX, Hong LV, et al. Dextran coated magnetite high susceptibility nanoparticles for hyperthermia applications. J Magn Magn Mater. 2018;460:128–136. doi:10.1016/j.jmmm.2018.03.065
   Web of Science ®Google Scholar
• Jadhav NV, Prasad AI, Kumar A, et al. Synthesis of oleic acid functionalized Fe3O4 magnetic nanoparticles and studying their interaction with tumor cells for potential hyperthermia applications. Colloids Surf B Biointerfaces. 2013;108:158–168. doi:10.1016/j.colsurfb.2013.02.03523537834
   PubMed Web of Science ®Google Scholar
• Tăculescu E, Coricovac D, Soica C, Pinzaru I, Păcurariu C, Dehelean C. Preclinical Aspects on Magnetic Iron Oxide Nanoparticles and Their Interventions as Anticancer Agents: Enucleation, Apoptosis and Other Mechanism. IntechOpen; 2018.
   Google Scholar
• Pisha E, Chai H, Lee S, et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med. 1995;1:1046–1051. doi:10.1038/nm1095-10467489361
   PubMed Web of Science ®Google Scholar
• Mullauer FB, Kessler JH, Medema JP. Betulinic acid, a natural compound with potent anticancer effects. Anticancer Drugs. 2010;21(3):215–227. doi:10.1097/CAD.0b013e3283357c6220075711
   PubMed Web of Science ®Google Scholar
• Kumar P, Bhadauria AS, Singh AK, Saha S. Betulinic acid as apoptosis activator: molecular mechanisms, mathematical modeling and chemical modifications. Life Sci. 2018;209:24–33. doi:10.1016/j.lfs.2018.07.05630076920
   PubMed Web of Science ®Google Scholar
• Saneja A, Arora D, Kumar R, Dubey RD, Panda AK, Gupta PN. Therapeutic applications of betulinic acid nanoformulations. Ann N Y Acad Sci. 2018;1421(1):5–18. doi:10.1111/nyas.1357029377164
   PubMed Web of Science ®Google Scholar
• Soica C, Trandafirescu C, Danciu C, Muntean D, Dehelean C, Simu G. New improved drug delivery technologies for pentacyclic triterpenes: a review. Protein Pept Lett. 2014;21(11):1137–1145. doi:10.2174/092986652166614080711510925106907
   PubMed Web of Science ®Google Scholar
• Lorente C, Cabeza L, Clares B, et al. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy. Colloids Surf B Biointerfaces. 2018;171:553–565. doi:10.1016/j.colsurfb.2018.07.07030096477
   PubMed Web of Science ®Google Scholar
• Dadwal A, Baldi A, Kumar Narang R. Nanoparticles as carriers for drug delivery in cancer. Artif Cells Nanomed Biotechnol. 2018;46(sup2):295–305. doi:10.1080/21691401.2018.145703930043651
   PubMed Web of Science ®Google Scholar
• Bixner O, Reimhult E. Controlled magnetosomes: embedding of magnetic nanoparticles into membranes of monodisperse lipid vesicles. J Colloid Interface Sci. 2016;466:62–71. doi:10.1016/j.jcis.2015.11.07126707773
   PubMed Web of Science ®Google Scholar
• Rodrigues ARO, Mendes PMF, Silva PML, et al. Solid and aqueous magnetoliposomes as nanocarriers for a new potential drug active against breast cancer. Colloids Surf B Biointerfaces. 2017;158:460–468. doi:10.1016/j.colsurfb.2017.07.01528732311
   PubMed Web of Science ®Google Scholar
• Andhale VA, Patil PR, Dhas AU, Chauhan PD, Desai SV. Liposome: an emerging tool in drug carrier system. J Pharm Tech. 2016;8:10982–11011.
   Google Scholar
• Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. 2008;58(2):97–110. doi:10.3322/CA.2007.000318227410
   PubMed Web of Science ®Google Scholar
• Ianoş R, Tăculescu E, Păcurariu C, Lazău I, Joy P. Solution Combustion Synthesis and Characterization of Magnetite, Fe3O4, Nanopowders. J Am Ceram Soc. 2012;95:2236–2240. doi:10.1111/j.1551-2916.2012.05159.x
   Web of Science ®Google Scholar
• Sabate R, Barnadas-Rodriguez R, Callejas-Fernandez J, Hidalgo-Alvarez R, Estelrich J. Preparation and characterization of extruded magnetoliposomes. Int J Pharm. 2008;347(1–2):156–162. doi:10.1016/j.ijpharm.2007.06.04717692483
   PubMed Web of Science ®Google Scholar
• Wildeboer R, Southern P, Pankhurst Q. On the reliable measurement of specific absorption rates and intrinsic loss parameters in magnetic hyperthermia materials. J Phys D Appl Phys. 2014;47:495003. doi:10.1088/0022-3727/47/49/495003
   Web of Science ®Google Scholar
• Iacob N, Schinteie G, Palade P, Ticos C, Kuncser V. Stepped heating procedure for experimental SAR evaluation of ferrofluids. Eur Phys J E Soft Matter. 2015;38:142. doi:10.1140/epje/i2015-15057-8
   Web of Science ®Google Scholar
• Skouras A, Papadia K, Mourtas S, Klepetsanis P, Antimisiaris SG. Multifunctional doxorubicin-loaded magnetoliposomes with active and magnetic targeting properties. Eur J Pharm Sci. 2018;123:162–172. doi:10.1016/j.ejps.2018.07.04430041027
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang X, Liu Z, et al. Gold nanoshell-based betulinic acid liposomes for synergistic chemo-photothermal therapy. Nanomedicine. 2017;13(6):1891–1900. doi:10.1016/j.nano.2017.03.01228363771
   PubMed Web of Science ®Google Scholar
• Zhu L, Huo Z, Wang L, Tong X, Xiao Y, Ni K. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes. Int J Pharm. 2009;370(1–2):136–143. doi:10.1016/j.ijpharm.2008.12.00319114095
   PubMed Web of Science ®Google Scholar
• Poller JM, Zaloga J, Schreiber E, et al. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Int J Nanomedicine. 2017;12:3207–3220. doi:10.2147/IJN.S13236928458541
   PubMed Web of Science ®Google Scholar
• Volk J, Engelmann J, Leyhausen G, Geurtsen W. Effects of three resin monomers on the cellular glutathione concentration of cultured human gingival fibroblasts. Dent Mater. 2006;22(6):499–505. doi:10.1016/j.dental.2005.06.00216198408
   PubMed Web of Science ®Google Scholar
• Kossatz S, Ludwig R, Dähring H, et al. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area. Pharm Res. 2014;31(12):3274–3288. doi:10.1007/s11095-014-1417-024890197
   PubMed Web of Science ®Google Scholar
• Patil JR, Jayaprakasha GK, Murthy KNC, Tichy SE, Chetti MB, Patil BS. Apoptosis-mediated proliferation inhibition of human colon cancer cells by volatile principles of Citrus aurantifolia. Food Chem. 2009;114(4):1351–1358. doi:10.1016/j.foodchem.2008.11.033
   Web of Science ®Google Scholar
• Ghitu A, Schwiebs A, Radeke HH, et al. A comprehensive assessment of apigenin as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound. Nutrients. 2019;11(4):858. doi:10.3390/nu11040858
   PubMed Web of Science ®Google Scholar
• Liang -C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2(2):329–333. doi:10.1038/nprot.2007.3017406593
   PubMed Web of Science ®Google Scholar
• Goetsch KP, Niesler CU. Optimization of the scratch assay for in vitro skeletal muscle wound healing analysis. Anal Biochem. 2011;411(1):158–160. doi:10.1016/j.ab.2010.12.01221146491
   PubMed Web of Science ®Google Scholar
• Felice F, Zambito Y, Belardinelli E, Fabiano A, Santoni T, Di Stefano R. Effect of different chitosan derivatives on in vitro scratch wound assay: a comparative study. Int J Biol Macromol. 2015;76:236–241. doi:10.1016/j.ijbiomac.2015.02.04125748846
   PubMed Web of Science ®Google Scholar
• Pavel IZ, Csuk R, Danciu C, et al. Assessment of the antiangiogenic and anti-inflammatory properties of a maslinic acid derivative and its potentiation using zinc chloride. Int J Mol Sci. 2019;20(11):2828. doi:10.3390/ijms20112828
   PubMed Web of Science ®Google Scholar
• Storgard C, Mikolon D, Stupack DG. Angiogenesis assays in the chick CAM. Methods Mol Biol. 2005;294:123–136. doi:10.1385/1-59259-860-9:12315576910
   PubMedGoogle Scholar
• Caunii A, Oprean C, Cristea M, et al. Effects of ursolic and oleanolic on SK‑MEL‑2 melanoma cells: in vitro and in vivo assays. Int J Oncol. 2017;51(6):1651–1660. doi:10.3892/ijo.2017.416029039461
   PubMed Web of Science ®Google Scholar
• Falamas A, Dehelean CA, Pinzaru SC. Monitoring of betulin nanoemulsion treatment and molecular changes in mouse skin cancer using surface enhanced Raman spectroscopy. Vib Spectrosc. 2018;95:44–50. doi:10.1016/j.vibspec.2018.01.004
   Web of Science ®Google Scholar
• Pinzaru I, Coricovac D, Dehelean C, et al. Stable PEG-coated silver nanoparticles - a comprehensive toxicological profile. Food Chem Toxicol. 2018;111:546–556. doi:10.1016/j.fct.2017.11.05129191727
   PubMed Web of Science ®Google Scholar
• Cinta Pinzaru S, Leopold N, Kiefer W. Vibrational spectroscopy of betulinic acid HIV inhibitor and of its birch bark natural source. Talanta. 2002;57(4):625–631. doi:10.1016/S0039-9140(02)00102-918968663
   PubMed Web of Science ®Google Scholar
• Khan S, Shah ZH, Riaz S, et al. Antimicrobial activity of citric acid functionalized iron oxide nanoparticles –Superparamagnetic effect. Ceram Int. 2020. doi:10.1016/j.ceramint.2020.01.109
   Web of Science ®Google Scholar
• Kawni I, Garcia R, Youssef S, Abboud M, Podlecki J, Habchi R. Stabilization and encapsulation of magnetite nanoparticles. Mater Res Express. 2016;3:125024. doi:10.1088/2053-1591/3/12/125024
   Web of Science ®Google Scholar
• Slavov L, Abrashev MV, Merodiiska T, et al. Raman spectroscopy investigation of magnetite nanoparticles in ferrofluids. J Magn Magn Mater. 2010;322(14):1904–1911. doi:10.1016/j.jmmm.2010.01.005
   Web of Science ®Google Scholar
• Testa-Anta M, Ramos-Docampo MA, Comesaña-Hermo M, Rivas-Murias B, Salgueiriño V. Raman spectroscopy to unravel the magnetic properties of iron oxide nanocrystals for bio-related applications. Nanoscale Adv. 2019;1(6):2086–2103. doi:10.1039/C9NA00064J
   PubMed Web of Science ®Google Scholar
• Franzé S, Selmin F, Samaritani E, Minghetti P, Cilurzo F. Lyophilization of liposomal formulations: still necessary, still challenging. Pharmaceutics. 2018;10(3):139. doi:10.3390/pharmaceutics10030139
   PubMed Web of Science ®Google Scholar
• Smith SM, Wunder MB, Norris DA, Shellman YG, Roemer K. A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One. 2011;6(11):e26908. doi:10.1371/journal.pone.002690822125603
   PubMed Web of Science ®Google Scholar
• Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm. 2005;288(2):369–376. doi:10.1016/j.ijpharm.2004.09.01815620877
   PubMed Web of Science ®Google Scholar
• Estanqueiro M, Amaral MH, Conceicao J, Sousa Lobo JM. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf B Biointerfaces. 2015;126:631–648. doi:10.1016/j.colsurfb.2014.12.04125591851
   PubMed Web of Science ®Google Scholar
• Wachsberger PR, Burd R, Wahl ML, Leeper DB. Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia. Int J Hyperth. 2002;18(2):153–164. doi:10.1080/02656730110091333
   PubMed Web of Science ®Google Scholar
• Moaca E-A, Farcas C, Coricovac D, Loghin F, Dehelean C-A, Pacurariu C. Citric acid coated magnetic iron oxide nanoparticles (Fe3O4): synthesis, characterization and applications. In: The 5th Edition of Nanotech France 2019; International Conference and Exhibition; 2019; 157.
   Google Scholar
• Ong SGM, Chitneni M, Lee KS, Ming LC, Yuen KH. Evaluation of extrusion technique for nanosizing liposomes. Pharmaceutics. 2016;8(4):36. doi:10.3390/pharmaceutics8040036
   PubMed Web of Science ®Google Scholar
• Faria MR, Cruz MM, Goncalves MC, Carvalho A, Feio G, Martins MBF. Synthesis and characterization of magnetoliposomes for MRI contrast enhancement. Int J Pharm. 2013;446(1–2):183–190. doi:10.1016/j.ijpharm.2013.02.02523422275
   PubMedGoogle Scholar
• Zhao T, Liu Y, Gao Z, et al. Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes. Mater Sci Eng C Mater Biol Appl. 2015;53:196–203. doi:10.1016/j.msec.2015.04.02226042707
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao D, Zhang X, et al. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes. Mater Sci Eng C Mater Biol Appl. 2016;64:124–132. doi:10.1016/j.msec.2016.03.08027127036
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48. doi:10.1016/j.addr.2012.09.03723036225
   PubMed Web of Science ®Google Scholar
• Kneidl B, Peller M, Winter G, Lindner LH, Hossann M. Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomedicine. 2014;9:4387–4398. doi:10.2147/IJN.S4929725258529
   PubMed Web of Science ®Google Scholar
• Kettering M, Winter J, Zeisberger M, et al. Magnetic nanoparticles as bimodal tools in magnetically induced labelling and magnetic heating of tumour cells: anin vitrostudy. Nanotechnology. 2007;18(17):175101. doi:10.1088/0957-4484/18/17/175101
   Web of Science ®Google Scholar
• Dutz S, Kettering M, Hilger I, Müller R, Zeisberger M. Magnetic multicore nanoparticles for hyperthermia-influence of particle immobilization in tumour tissue on magnetic properties. Nanotechnology. 2011;22:265102. doi:10.1088/0957-4484/22/26/26510221576784
   PubMed Web of Science ®Google Scholar
• Laurent S, Dutz S, Hafeli UO, Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 2011;166(1–2):8–23. doi:10.1016/j.cis.2011.04.00321601820
   PubMed Web of Science ®Google Scholar
• Putz A-M, Ianasi C, Dudas Z, et al. SiO2-PVA-Fe(acac)3 hybrid based superparamagnetic nanocomposites for nanomedicine: morpho-textural evaluation and in vitro cytotoxicity assay. Molecules. 2020;25(3):653. doi:10.3390/molecules25030653
   PubMed Web of Science ®Google Scholar
• Moaca E-A, Farcas C, Coricovac D, et al. Oleic acid double coated Fe(3)O(4) nanoparticles as anti-melanoma compounds with a complex mechanism of activity-in vitro and in ovo assessment. J Biomed Nanotechnol. 2019;15(5):893–909. doi:10.1166/jbn.2019.272630890222
   PubMed Web of Science ®Google Scholar
• Farcas CG, Macasoi I, Pinzaru I, et al. Controlled synthesis and characterization of micrometric single crystalline magnetite with superparamagnetic behavior and cytocompatibility/cytotoxicity assessments. Front Pharmacol. 2020;11:410. doi:10.3389/fphar.2020.0041032317973
   PubMed Web of Science ®Google Scholar
• Soica C, Danciu C, Savoiu-Balint G, et al. Betulinic acid in complex with a gamma-cyclodextrin derivative decreases proliferation and in vivo tumor development of non-metastatic and metastatic B164A5 cells. Int J Mol Sci. 2014;15(5):8235–8255. doi:10.3390/ijms1505823524821543
   PubMed Web of Science ®Google Scholar
• Soica C, Dehelean C, Danciu C, et al. Betulin complex in gamma-cyclodextrin derivatives: properties and antineoplastic activities in in vitro and in vivo tumor models. Int J Mol Sci. 2012;13(11):14992–15011. doi:10.3390/ijms13111499223203108
   PubMed Web of Science ®Google Scholar
• Pilco-Ferreto N, Calaf G. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int J Oncol. 2016;49:753–762. doi:10.3892/ijo.2016.355827278553
   PubMed Web of Science ®Google Scholar
• Zheng Y, Liu P, Wang N, et al. Betulinic acid suppresses breast cancer metastasis by targeting GRP78-mediated glycolysis and ER stress apoptotic pathway. Oxid Med Cell Longev. 2019;2019:8781690. doi:10.1155/2019/878169031531187
   PubMed Web of Science ®Google Scholar
• Chaves NL, Estrela-Lopis I, Bottner J, et al. Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells. Int J Nanomedicine. 2017;12:5511–5523. doi:10.2147/IJN.S14158228814867
   PubMed Web of Science ®Google Scholar
• Lee YK, Choi E-J, Webster TJ, Kim S-H, Khang D. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int J Nanomedicine. 2015;10:97–113. doi:10.2147/IJN.S7299825565807
   PubMed Web of Science ®Google Scholar
• Ferraro E, Pesaresi MG, De Zio D, et al. Apaf1 plays a pro-survival role by regulating centrosome morphology and function. J Cell Sci. 2011;124(20):3450–3463. doi:10.1242/jcs.08629821984814
   PubMed Web of Science ®Google Scholar
• Field JJ, Kanakkanthara A, Miller JH. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. Bioorg Med Chem. 2014;22(18):5050–5059. doi:10.1016/j.bmc.2014.02.03524650703
   PubMed Web of Science ®Google Scholar
• Madiraju C, Edler MC, Hamel E, et al. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin. Biochemistry. 2005;44(45):15053–15063. doi:10.1021/bi050685l16274252
   PubMed Web of Science ®Google Scholar
• Rohena CC, Risinger AL, Devambatla RKV, et al. Janus compounds, 5-chloro-N4-methyl-N4-aryl-9H-pyrimido[4,5-b]indole-2,4-diamines, cause both microtubule depolymerizing and stabilizing effects. Molecules. 2016;21(12):1661. doi:10.3390/molecules21121661
   PubMed Web of Science ®Google Scholar
• Fanale D, Bronte G, Passiglia F, et al. Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option? Anal Cell Pathol (Amst). 2015;2015:690916. doi:10.1155/2015/69091626484003
   PubMedGoogle Scholar
• Buey RM, Barasoain I, Jackson E, et al. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Chem Biol. 2005;12(12):1269–1279. doi:10.1016/j.chembiol.2005.09.01016356844
   PubMedGoogle Scholar
• Lu S-J, Feng Q, Park JS, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112(12):4475–4484. doi:10.1182/blood-2008-05-15719818713948
   PubMed Web of Science ®Google Scholar
• Prescott DM, Myerson D, Wallace J. Enucleation of mammalian cells with cytochalasin B. Exp Cell Res. 1972;71(2):480–485. doi:10.1016/0014-4827(72)90322-95065231
   PubMed Web of Science ®Google Scholar
• Paunescu V, Bojin FM, Gavriliuc OI, et al. Enucleation: a possible mechanism of cancer cell death. J Cell Mol Med. 2014;18(6):962–965. doi:10.1111/jcmm.1227124629135
   PubMed Web of Science ®Google Scholar
• Dehelean CA, Feflea S, Ganta S, Amiji M. Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay. J Biomed Nanotechnol. 2011;7(2):317–324. doi:10.1166/jbn.2011.129721702370
   PubMed Web of Science ®Google Scholar
• Ribatti D. The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model. Mech Dev. 2016;141:70–77. doi:10.1016/j.mod.2016.05.00327178379
   PubMed Web of Science ®Google Scholar
• Nik ME, Malaekeh-Nikouei B, Amin M, et al. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma. Sci Rep. 2019;9(1):9527. doi:10.1038/s41598-019-45974-731267009
   PubMed Web of Science ®Google Scholar
• Ribatti D, Nico B, Ruggieri S, Tamma R, Simone G, Mangia A. Angiogenesis and antiangiogenesis in triple-negative breast cancer. Transl Oncol. 2016;9(5):453–457. doi:10.1016/j.tranon.2016.07.00227751350
   PubMed Web of Science ®Google Scholar
• Farcas CG, Moaca EA, Dragoi R, et al. Preliminary results of betulinic acid-loaded magnetoliposomes - A potential approach to increase therapeutic efficacy in melanoma. Rev Chim. 2019;70(9):3372–3377. doi:10.37358/rc.19.9.7552
   Web of Science ®Google Scholar
• Farcas C, Tăculescu E, Coricovac D, Dehelean C, Loghin F. In vitro antiproliferative effects of Fe3O4_BA loaded liposomes. Toxicol Lett. 2018;295:S113. doi:10.1016/j.toxlet.2018.06.646
   Web of Science ®Google Scholar